Close Menu

NEW YORK (360Dx) – Accelerate Diagnostics reported after the close of the market on Monday that its second quarter revenues jumped 143 percent year over year but fell short of Wall Street expectations.

For the three months ended June 30, 2018, the company's revenues rose to $1.7 million compared to $699,000 in Q2 2017. The analysts' average estimate was $2.1 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.